The chemistry and biology of oligonucleotide conjugates

Accounts of Chemical Research

Volumn 45, Issue 7, 2012, Pages 1067-1076

  Juliano, R L ^a   Ming, Xin ^a   Nakagawa, Osamu ^a  

^a University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CARBOHYDRATE; LIPID; MESSENGER RNA; MICRORNA; NUCLEIC ACID; OLIGONUCLEOTIDE; PEPTIDE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CHEMISTRY; GENETIC TRANSFECTION; HUMAN; METABOLISM; MOUSE;

ANIMALS; CARBOHYDRATES; HUMANS; LIPIDS; MICE; MICRORNAS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84860707063     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar2002123     Document Type: Article

References (66)

1. Corey, D. R. RNA learns from antisense Nat. Chem. Biol. 2007, 3, 8-11
2. Kurreck, J. RNA interference: from basic research to therapeutic applications Angew. Chem. 2009, 48, 1378-1398
3. Moazed, D. Small RNAs in transcriptional gene silencing and genome defence Nature 2009, 457, 413-420
4. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001, 411, 494-498
5. Djuranovic, S.; Nahvi, A.; Green, R. A parsimonious model for gene regulation by miRNAs Science 2011, 331, 550-553
6. Eulalio, A.; Behm-Ansmant, I.; Izaurralde, E. P bodies: at the crossroads of post-transcriptional pathways Nat. Rev. Mol. Cell Biol. 2007, 8, 9-22
7. Rossbach, M. Small non-coding RNAs as novel therapeutics Curr. Mol. Med. 2010, 10, 361-368
8. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with "antagomirs" Nature 2005, 438, 685-689
9. Sazani, P.; Kole, R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing J Clin Invest 2003, 112, 481-486
10. Ming, X.; Alam, M. R.; Fisher, M.; Yan, Y.; Chen, X.; Juliano, R. L. Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor Nucleic Acids Res. 2010, 38, 6567-76
11. Thiel, K. W.; Giangrande, P. H. Therapeutic applications of DNA and RNA aptamers Oligonucleotides 2009, 19, 209-222
12. Miyake, K. Nucleic acid-sensing Toll-like receptors: beyond ligand search Adv. Drug Delivery Rev. 2008, 60, 782-785
13. Bennett, C. F.; Swayze, E. E. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform Annu. Rev. Pharmacol. Toxicol. 2010, 50, 259-293
14. Geary, R. S. Antisense oligonucleotide pharmacokinetics and metabolism Expert Opin. Drug Metab. Toxicol. 2009, 5, 381-391
15. Yamamoto, T.; Nakatani, M.; Narukawa, K.; Obika, S. Antisense drug discovery and development Future Med. Chem. 2011, 3, 339-365
16. Juliano, R.; Bauman, J.; Kang, H.; Ming, X. Biological barriers to therapy with antisense and siRNA oligonucleotides Mol. Pharmaceutics 2009, 6, 686-695
17. Molitoris, B. A.; Dagher, P. C.; Sandoval, R. M.; Campos, S. B.; Ashush, H.; Fridman, E.; Brafman, A.; Faerman, A.; Atkinson, S. J.; Thompson, J. D.; Kalinski, H.; Skaliter, R.; Erlich, S.; Feinstein, E. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury J. Am. Soc. Nephrol. 2009, 20, 1754-1764
18. Alam, M. R.; Ming, X.; Dixit, V.; Fisher, M.; Chen, X.; Juliano, R. L. The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking Oligonucleotides 2010, 20, 103-109
19. Ming, X. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis Expert Opin. Drug Delivery 2011, 8, 435-449
20. Ming, X.; Sato, K.; Juliano, R. L. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes J. Controlled Release 2011, 153, 83-92
21. Koller, E.; Vincent, T. M.; Chappell, A.; De, S.; Manoharan, M.; Bennett, C. F. Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes Nucleic Acids Res. 2011, 39, 4795-4807
22. Doherty, G. J.; McMahon, H. T. Mechanisms of endocytosis Annu. Rev. Biochem. 2009, 78, 857-902
23. Juliano, R. L.; Ming, X.; Nakagawa, O. Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides Bioconjugate Chem. 2011, 23, 147-157
24. Vaishnaw, A. K.; Gollob, J.; Gamba-Vitalo, C.; Hutabarat, R.; Sah, D.; Meyers, R.; de Fougerolles, T.; Maraganore, J. A status report on RNAi therapeutics Silence 2010, 1, 14
25. Zamora, M. R.; Budev, M.; Rolfe, M.; Gottlieb, J.; Humar, A.; Devincenzo, J.; Vaishnaw, A.; Cehelsky, J.; Albert, G.; Nochur, S.; Gollob, J. A.; Glanville, A. R. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus Am. J. Respir. Crit. Care Med. 2011, 183, 531-538
26. Bell, D. A.; Hooper, A. J.; Burnett, J. R. Mipomersen, an antisense apolipoprotein B synthesis inhibitor Expert Opin. Invest. Drugs 2011, 20, 265-272
27. Cirak, S.; Arechavala-Gomeza, V.; Guglieri, M.; Feng, L.; Torelli, S.; Anthony, K.; Abbs, S.; Garralda, M. E.; Bourke, J.; Wells, D. J.; Dickson, G.; Wood, M. J.; Wilton, S. D.; Straub, V.; Kole, R.; Shrewsbury, S. B.; Sewry, C.; Morgan, J. E.; Bushby, K.; Muntoni, F. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Lancet 2011, 378, 595-605
28. Hammond, S. M.; Wood, M. J. PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy Curr. Opin. Mol. Ther. 2010, 12, 478-486
29. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discovery 2009, 8, 129-138
30. Tseng, Y. C.; Mozumdar, S.; Huang, L. Lipid-based systemic delivery of siRNA Adv. Drug Delivery Rev. 2009, 61, 721-731
31. Tamura, A.; Nagasaki, Y. Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles Nanomedicine (London, U.K.) 2010, 5, 1089-1102
32. Marlin, F.; Simon, P.; Saison-Behmoaras, T.; Giovannangeli, C. Delivery of oligonucleotides and analogues: the oligonucleotide conjugate-based approach ChemBioChem 2010, 11, 1493-1500
33. Singh, Y.; Murat, P.; Defrancq, E. Recent developments in oligonucleotide conjugation Chem. Soc. Rev. 2010, 39, 2054-2070
34. Lonnberg, H. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics Bioconjugate Chem. 2009, 20, 1065-1094
35. Meyer, A.; Spinelli, N.; Dumy, P.; Vasseur, J. J.; Morvan, F.; Defrancq, E. Oligonucleotide sequential bis-conjugation via click-oxime and click-Huisgen procedures J. Org. Chem. 2010, 75, 3927-3930
36. Yamada, T.; Peng, C. G.; Matsuda, S.; Addepalli, H.; Jayaprakash, K. N.; Alam, M. R.; Mills, K.; Maier, M. A.; Charisse, K.; Sekine, M.; Manoharan, M.; Rajeev, K. G. Versatile site-specific conjugation of small molecules to siRNA using click chemistry J. Org. Chem. 2011, 76, 1198-1211
37. Wang, T. P.; Chiou, Y. J.; Chen, Y.; Wang, E. C.; Hwang, L. C.; Chen, B. H.; Chen, Y. H.; Ko, C. H. Versatile phosphoramidation reactions for nucleic acid conjugations with peptides, proteins, chromophores, and biotin derivatives Bioconjugate Chem. 2010, 21, 1642-1655
38. Lebleu, B.; Moulton, H. M.; Abes, R.; Ivanova, G. D.; Abes, S.; Stein, D. A.; Iversen, P. L.; Arzumanov, A. A.; Gait, M. J. Cell penetrating peptide conjugates of steric block oligonucleotides Adv. Drug Delivery Rev. 2008, 60, 517-529
39. Said Hassane, F.; Saleh, A. F.; Abes, R.; Gait, M. J.; Lebleu, B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides Cell. Mol. Life Sci. 2010, 67, 715-726
40. Alam, M. R.; Dixit, V.; Kang, H.; Li, Z. B.; Chen, X.; Trejo, J.; Fisher, M.; Juliano, R. L. Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis Nucleic Acids Res. 2008, 36, 2764-2776
41. Astriab-Fisher, A.; Sergueev, D.; Fisher, M.; Shaw, B. R.; Juliano, R. L. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions Pharm. Res. 2002, 19, 744-754
42. Turner, J. J.; Arzumanov, A. A.; Gait, M. J. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides Nucleic Acids Res. 2005, 33, 27-42
43. Wolfrum, C.; Shi, S.; Jayaprakash, K. N.; Jayaraman, M.; Wang, G.; Pandey, R. K.; Rajeev, K. G.; Nakayama, T.; Charrise, K.; Ndungo, E. M.; Zimmermann, T.; Koteliansky, V.; Manoharan, M.; Stoffel, M. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Nat. Biotechnol. 2007, 25, 1149-1157
44. Nishina, K.; Unno, T.; Uno, Y.; Kubodera, T.; Kanouchi, T.; Mizusawa, H.; Yokota, T. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol Mol. Ther. 2008, 16, 734-740
45. Patwa, A.; Gissot, A.; Bestel, I.; Barthelemy, P. Hybrid lipid oligonucleotide conjugates: synthesis, self-assemblies and biomedical applications Chem Soc Rev 2011, 40, 5844-5854
46. Kiviniemi, A.; Virta, P.; Drenichev, M. S.; Mikhailov, S. N.; Lonnberg, H. Solid-Supported 2′-O-Glycoconjugation of Oligonucleotides by Azidation and Click Reactions Bioconjugate Chem. 2011, 22, 1249-1255
47. Pourceau, G.; Meyer, A.; Vasseur, J. J.; Morvan, F. Synthesis of a Glycomimetic Oligonucleotide Conjugate by 1,3-Dipolar Cycloaddition Methods Mol. Biol. 2011, 751, 167-193
48. Dassie, J. P.; Liu, X. Y.; Thomas, G. S.; Whitaker, R. M.; Thiel, K. W.; Stockdale, K. R.; Meyerholz, D. K.; McCaffrey, A. P.; McNamara, J. O., 2nd; Giangrande, P. H. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors Nat. Biotechnol. 2009, 27, 839-849
49. Neff, C. P.; Zhou, J.; Remling, L.; Kuruvilla, J.; Zhang, J.; Li, H.; Smith, D. D.; Swiderski, P.; Rossi, J. J.; Akkina, R. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice Sci. Transl. Med. 2011, 3, 66ra6
50. Juliano, R.; Alam, M. R.; Dixit, V.; Kang, H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res. 2008, 36, 4158-4171
51. Nakagawa, O.; Ming, X.; Huang, L.; Juliano, R. L. Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands J. Am. Chem. Soc. 2010, 132, 8848-8849
52. Alam, M. R.; Ming, X.; Fisher, M.; Lackey, J. G.; Rajeev, K. G.; Manoharan, M.; Juliano, R. L. Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA Bioconjugate Chem. 2011, 22, 1673-1681
53. Kortylewski, M.; Swiderski, P.; Herrmann, A.; Wang, L.; Kowolik, C.; Kujawski, M.; Lee, H.; Scuto, A.; Liu, Y.; Yang, C.; Deng, J.; Soifer, H. S.; Raubitschek, A.; Forman, S.; Rossi, J. J.; Pardoll, D. M.; Jove, R.; Yu, H. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses Nat. Biotechnol. 2009, 27, 925-932
54. McNamara, J. O., 2nd; Andrechek, E. R.; Wang, Y.; Viles, K. D.; Rempel, R. E.; Gilboa, E.; Sullenger, B. A.; Giangrande, P. H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 2006, 24, 1005-1015
55. Wheeler, L. A.; Trifonova, R.; Vrbanac, V.; Basar, E.; McKernan, S.; Xu, Z.; Seung, E.; Deruaz, M.; Dudek, T.; Einarsson, J. I.; Yang, L.; Allen, T. M.; Luster, A. D.; Tager, A. M.; Dykxhoorn, D. M.; Lieberman, J. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras J. Clin. Invest. 2011, 121, 2401-2412
56. Pastor, F.; Kolonias, D.; Giangrande, P. H.; Gilboa, E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay Nature 2010, 465, 227-230
57. Lindgren, M.; Langel, U. Classes and prediction of cell-penetrating peptides Methods Mol. Biol. 2011, 683, 3-19
58. Juliano, R. L.; Alam, R.; Dixit, V.; Kang, H. M. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1, 324-335
59. El-Andaloussi, S.; Jarver, P.; Johansson, H. J.; Langel, U. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem. J. 2007, 407, 285-292
60. Tunnemann, G.; Martin, R. M.; Haupt, S.; Patsch, C.; Edenhofer, F.; Cardoso, M. C. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J. 2006, 20, 1775-1784
61. Ivanova, G. D.; Arzumanov, A.; Abes, R.; Yin, H.; Wood, M. J.; Lebleu, B.; Gait, M. J. Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle Nucleic Acids Res. 2008, 36, 6418-6428
62. Abes, R.; Moulton, H. M.; Clair, P.; Yang, S. T.; Abes, S.; Melikov, K.; Prevot, P.; Youngblood, D. S.; Iversen, P. L.; Chernomordik, L. V.; Lebleu, B. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies Nucleic Acids Res. 2008, 36, 6343-6354
63. Yin, H.; Saleh, A. F.; Betts, C.; Camelliti, P.; Seow, Y.; Ashraf, S.; Arzumanov, A.; Hammond, S.; Merritt, T.; Gait, M. J.; Wood, M. J. Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice Mol. Ther. 2011, 19, 1295-1303
64. Goyenvalle, A.; Babbs, A.; Powell, D.; Kole, R.; Fletcher, S.; Wilton, S. D.; Davies, K. E. Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping Mol. Ther. 2010, 18, 198-205
65. Koppelhus, U.; Shiraishi, T.; Zachar, V.; Pankratova, S.; Nielsen, P. E. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain Bioconjugate Chem. 2008, 19, 1526-1534
66. Nakase, I.; Akita, H.; Kogure, K.; Graslund, A.; Langel, U.; Harashima, H.; Futaki, S. Efficient Intracellular Delivery of Nucleic Acid Pharmaceuticals Using Cell-Penetrating Peptides. Acc. Chem. Res. 2011, not supplied.